Abionyx Pharma (XPAR:ABNX) Total Stockholders Equity : €7.92 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Abionyx Pharma Total Stockholders Equity?

Abionyx Pharma's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €7.92 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Abionyx Pharma's Book Value per Share for the quarter that ended in Dec. 2023 was €0.25. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Abionyx Pharma's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.43.

Abionyx Pharma Total Stockholders Equity Historical Data

The historical data trend for Abionyx Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abionyx Pharma Total Stockholders Equity Chart

Abionyx Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

6.67

6.63

10.68

7.17

7.92

Abionyx Pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															10.68	8.64	7.17	4.79	7.92

Abionyx Pharma (XPAR:ABNX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Abionyx Pharma's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(7.922	-	0)	/	32.1916
	=	0.25

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Abionyx Pharma's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.815	+	2.575)	/	7.922
	=	0.43

Abionyx Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Abionyx Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Abionyx Pharma (XPAR:ABNX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abionyx Pharma (XPAR:ABNX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

609:Germany

Address

33-43 Avenue Georges Pompidou-Bat D2, Balma, FRA, 31130

Website

https://www.abionyx.com

Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.

Abionyx Pharma (XPAR:ABNX) Headlines

No Headlines